UPDATE : Monday, December 10, 2018
AstraZeneca Korea’s antiplatelet therapy gets insurance coverage
AstraZeneca Korea said Thursday that a 60 mg dose of its oral antiplatelet ...
by Marian Chu  |  2018-05-04 11:56
Hanmi posts ₩245.7 billion in Q1 sales
Hanmi Pharmaceutical said Thursday that it recorded 245.7 billion won ($228...
by Lee Han-soo  |  2018-05-03 14:52
How much cheaper will Keytruda be as first-line treatment?
The pharmaceutical industry is paying attention to how much the price of MS...
by Nam Doo-hyun  |  2018-05-03 14:51
SK Chemicals approves spinoff of its vaccine biz
SK Chemicals said Thursday that the company’s board of directors has approv...
by Lee Han-soo  |  2018-05-03 14:33
Abbvie applies for European marketing approval for investigational psoriasis therapy
Illinois-based pharmaceutical firm Abbvie has submitted a marketing authori...
by Marian Chu  |  2018-05-03 13:12
Roche gets expanded reimbursement for ovarian cancer therapy
Roche Korea (CEO: Matt Sause) said that its targeted therapy Avastin (ingre...
by Marian Chu  |  2018-05-02 18:17
Lilly Korea’s gastric cancer drug gets expanded reimbursement
The Korean branch of Eli Lilly and Company said that its gastric cancer the...
by Marian Chu  |  2018-05-02 17:13
JW Pharma, Syntekabio agree to develop new drugs using AI
JW Pharmaceutical said Wednesday that it has signed a memorandum of underst...
by Lee Han-soo  |  2018-05-02 16:33
Gtree presents dry eye treatment at US conference
Gtree BNT said Wednesday that it has presented data regarding RGN-259, a dr...
by Lee Han-soo  |  2018-05-02 15:37
Bayer’s liver cancer drug gets more reimbursement as 2nd line therapy
Bayer Korea’s targeted liver cancer therapy Stivarga (ingredient: regorafen...
by Marian Chu  |  2018-05-02 15:36
Genexine, Roche to research combination treatment for cancer
Genexine and its U.S. subsidiary NeoImmuneTech said Wednesday they have sig...
by Lee Han-soo  |  2018-05-02 15:13
US court dismisses Medytox’s suit against Daewoong without prejudice
The war of nerves between Daewoong Pharmaceuticals and Medytox over the ori...
by Lee Han-soo  |  2018-04-30 17:31
Korean pharma firms target rare diseases to enter US market
Domestic pharmaceutical companies are targeting the U.S. market with rare d...
by So Jae-hyeon  |  2018-04-30 16:42
LG Chem unveil premium hyaluronic acid filler
LG Chem said Monday that it has released Y-Solution, the company’s premium ...
by Lee Han-soo  |  2018-04-30 15:29
Huons to export BTX to Europe
Huons said Monday that it has signed a contract to export Hutox, its botuli...
by Lee Han-soo  |  2018-04-30 14:14
Top 10 eye-drug revenues rise in 2017
The market for eye disease therapies is becoming hotter as fine dust pollut...
by Nam Doo-hyun  |  2018-04-30 11:31
Huons receives GMP certification in Saudi
Huons said Friday that it has received good manufacturing practice (GMP) ce...
by Lee Han-soo  |  2018-04-27 17:48
Ildong presents cancer treatment at US conference
Visitors view Ildong’s research results on anti-cancer drug candidates at t...
by Lee Han-soo  |  2018-04-27 17:12
Will US oncology conference boost Korean biotech shares?
Whether the upcoming annual meeting of the American Society of Clinical Onc...
by Nam Doo-hyun  |  2018-04-27 16:29
‘Sanofi Korea’s Dupixent has low possibility of reimbursement’
Sanofi-Aventis Korea has finally launched its atopic dermatitis therapy Dup...
by Marian Chu  |  2018-04-26 17:01
Back to Top